Management of nontuberculous mycobacterial infection in the elderly

Mehdi Mirsaeidi, Maham Farshidpour, Golnaz Ebrahimi, Stefano Aliberti, Joseph O. Falkinham

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The incidence of nontuberculous mycobacteria (NTM) has increased over the last decades. Elderly people are more susceptible to NTM and experience increased morbidities. NTM incidence is expected to rise due to an increasing elderly population at least up to 2050. Given the importance of NTM infection in the elderly, an increasing interest exists in studying NTM characteristics in the aged population. In this review, we summarize the characteristics of NTM infection among elderly patients. We focus on epidemiology, clinical presentation, and treatment options of NTM in this age group. We highlight the differences in the diagnosis and treatment between rapid and slow growing mycobacterial infections. The current recommendation for treatment of NTM is discussed. We debate if in vitro susceptibility testing has a role in the treatment of NTM. Drug-drug interaction between antibiotics used to treat NTM and other medications, particularly warfarin, is another important issue that we discuss. Finally, we review the prognosis of NTM disease in elderly patients.

Original languageEnglish (US)
Pages (from-to)356-363
Number of pages8
JournalEuropean Journal of Internal Medicine
Volume25
Issue number4
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Nontuberculous Mycobacteria
Infection
Nontuberculous Mycobacterium Infections
Incidence
Warfarin
Therapeutics
Drug Interactions
Population
Epidemiology
Age Groups
Anti-Bacterial Agents
Morbidity

Keywords

  • Elderly
  • Nontuberculous mycobacterium
  • NTM
  • Treatment

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Management of nontuberculous mycobacterial infection in the elderly. / Mirsaeidi, Mehdi; Farshidpour, Maham; Ebrahimi, Golnaz; Aliberti, Stefano; Falkinham, Joseph O.

In: European Journal of Internal Medicine, Vol. 25, No. 4, 2014, p. 356-363.

Research output: Contribution to journalArticle

Mirsaeidi, Mehdi ; Farshidpour, Maham ; Ebrahimi, Golnaz ; Aliberti, Stefano ; Falkinham, Joseph O. / Management of nontuberculous mycobacterial infection in the elderly. In: European Journal of Internal Medicine. 2014 ; Vol. 25, No. 4. pp. 356-363.
@article{2d42e2f716024f21ba50137b3e2cba48,
title = "Management of nontuberculous mycobacterial infection in the elderly",
abstract = "The incidence of nontuberculous mycobacteria (NTM) has increased over the last decades. Elderly people are more susceptible to NTM and experience increased morbidities. NTM incidence is expected to rise due to an increasing elderly population at least up to 2050. Given the importance of NTM infection in the elderly, an increasing interest exists in studying NTM characteristics in the aged population. In this review, we summarize the characteristics of NTM infection among elderly patients. We focus on epidemiology, clinical presentation, and treatment options of NTM in this age group. We highlight the differences in the diagnosis and treatment between rapid and slow growing mycobacterial infections. The current recommendation for treatment of NTM is discussed. We debate if in vitro susceptibility testing has a role in the treatment of NTM. Drug-drug interaction between antibiotics used to treat NTM and other medications, particularly warfarin, is another important issue that we discuss. Finally, we review the prognosis of NTM disease in elderly patients.",
keywords = "Elderly, Nontuberculous mycobacterium, NTM, Treatment",
author = "Mehdi Mirsaeidi and Maham Farshidpour and Golnaz Ebrahimi and Stefano Aliberti and Falkinham, {Joseph O.}",
year = "2014",
doi = "10.1016/j.ejim.2014.03.008",
language = "English (US)",
volume = "25",
pages = "356--363",
journal = "European Journal of Internal Medicine",
issn = "0953-6205",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Management of nontuberculous mycobacterial infection in the elderly

AU - Mirsaeidi, Mehdi

AU - Farshidpour, Maham

AU - Ebrahimi, Golnaz

AU - Aliberti, Stefano

AU - Falkinham, Joseph O.

PY - 2014

Y1 - 2014

N2 - The incidence of nontuberculous mycobacteria (NTM) has increased over the last decades. Elderly people are more susceptible to NTM and experience increased morbidities. NTM incidence is expected to rise due to an increasing elderly population at least up to 2050. Given the importance of NTM infection in the elderly, an increasing interest exists in studying NTM characteristics in the aged population. In this review, we summarize the characteristics of NTM infection among elderly patients. We focus on epidemiology, clinical presentation, and treatment options of NTM in this age group. We highlight the differences in the diagnosis and treatment between rapid and slow growing mycobacterial infections. The current recommendation for treatment of NTM is discussed. We debate if in vitro susceptibility testing has a role in the treatment of NTM. Drug-drug interaction between antibiotics used to treat NTM and other medications, particularly warfarin, is another important issue that we discuss. Finally, we review the prognosis of NTM disease in elderly patients.

AB - The incidence of nontuberculous mycobacteria (NTM) has increased over the last decades. Elderly people are more susceptible to NTM and experience increased morbidities. NTM incidence is expected to rise due to an increasing elderly population at least up to 2050. Given the importance of NTM infection in the elderly, an increasing interest exists in studying NTM characteristics in the aged population. In this review, we summarize the characteristics of NTM infection among elderly patients. We focus on epidemiology, clinical presentation, and treatment options of NTM in this age group. We highlight the differences in the diagnosis and treatment between rapid and slow growing mycobacterial infections. The current recommendation for treatment of NTM is discussed. We debate if in vitro susceptibility testing has a role in the treatment of NTM. Drug-drug interaction between antibiotics used to treat NTM and other medications, particularly warfarin, is another important issue that we discuss. Finally, we review the prognosis of NTM disease in elderly patients.

KW - Elderly

KW - Nontuberculous mycobacterium

KW - NTM

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84899979377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899979377&partnerID=8YFLogxK

U2 - 10.1016/j.ejim.2014.03.008

DO - 10.1016/j.ejim.2014.03.008

M3 - Article

VL - 25

SP - 356

EP - 363

JO - European Journal of Internal Medicine

JF - European Journal of Internal Medicine

SN - 0953-6205

IS - 4

ER -